Evidence map›Paper›PMID 39067028›Full record

ArticleACS applied materials & interfaces2024

Development and Evaluation of Microencapsulated Oregano Essential Oil as an Alternative Treatment for

Liliana Fernandes, Ainara Barco-Tejada, Elena Blázquez, Daniela Araújo, Artur Ribeiro, Sónia Silva, Lorena Cussó, Sofia Costa-de-Oliveira, M Elisa Rodrigues, Mariana Henriques

Abstract read
In one paragraph

Article in ACS applied materials & interfaces, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Chemical Composition, Biocompatibility, and Anti-Pathogens (Basel, Switzerland) · 2025
    Article
  2. Review
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Liliana FernandesCentre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Ainara Barco-TejadaDepartamento de Bioingeniería, Universidad Carlos III de Madrid, 126, 28903 Getafe, Madrid, Spain.
Elena BlázquezDepartamento de Bioingeniería, Universidad Carlos III de Madrid, 126, 28903 Getafe, Madrid, Spain.
Daniela AraújoCentre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.
Artur RibeiroCentre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0003-3298-5564
Sónia SilvaCentre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0003-0000-7387
Lorena CussóDepartamento de Bioingeniería, Universidad Carlos III de Madrid, 126, 28903 Getafe, Madrid, Spain.
Sofia Costa-de-OliveiraDivision of Microbiology, Department of Pathology, and Center for Health Technology and Services Research - CINTESIS@RISE, Faculty of Medicine, University of Porto, 4200-450 Porto, Portugal.ORCID 0000-0003-2899-6615
M Elisa RodriguesCentre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.ORCID 0000-0001-8823-9494
Mariana HenriquesCentre of Biological Engineering, University of Minho, Campus de Gualtar, 4710-057 Braga, Portugal.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Vulvovaginal candidiasis (VVC) is characterized as a very common fungal infection that significantly affects women's health worldwide. Essential oils (EOs) are currently being evaluated as an alternative therapy. The development of efficient techniques such as micro- or nanoencapsulation for protecting and controlling release is essential to overcome the limitations of EO applications. Therefore, the aim of this study was to develop and characterize oregano EO-loaded keratin microparticles (OEO-KMPs) as a potential treatment for VVC. OEO-KMPs were produced using high-intensity ultrasonic cycles and characterized in terms of morphological and physicochemical parameters.

Indexed as

Antifungal AgentsCandida albicansCandidiasis, VulvovaginalMice, Inbred BALB COils, VolatileOriganumAnimalsBiofilmsFemaleHumansMiceMicrobial Sensitivity TestsAntifungal AgentsOils, VolatileBiofilm treatmentCandida albicansKeratin microcapsulesPhytotherapeutic applicationsVaginal microfloraVulvovaginal candidiasis

Identifiers

PMID39067028
PMCPMC11311128

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.